Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation

Nicotine and Tobacco Research

Volumn 2, Issue 4, 2000, Pages 371-378

  Shiffman, Saul ^a,d   Khayrallah, Moise ^b   Nowak, Robert ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Lineberry Associates   (United States)

^c SmithKline Beecham Consumer Healthcare   (United States)

^d PINNEY ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLION STIMULATING AGENT; NICOTINE;

ADULT; AFFECT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; AFFECT; DOUBLE-BLIND METHOD; FEMALE; GANGLIONIC STIMULANTS; HUMANS; MALE; MIDDLE AGED; NICOTINE; RECURRENCE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 85047676300     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/713688158     Document Type: Article

References (37)

1. Abelin T, Ehrsam R, Buhler-Reichert A, Imhof PR, Muller P, Thommen A, Vesanen K. 1989. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methodological Findings in Experimental and Clinical Pharmacology 11:205-214.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association.
3. Cummings KM, Giovino G, Jaen CR, Emrich LJ. 1985. Reports of smoking withdrawal symptoms over a 21 day period of abstinence. Addictive Behaviors 10:373-381.
4. Fiore MC, Jorenby DE, Baker TB, Kenford SL. 1992. Tobacco dependence and the nicotine patch: clinical guidelines for effective use. Journal of the American Medical Association 268:2687-2694.
5. Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. 1994. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest 105:524-533.
6. Fiore MC, Smith SS, Jorenby DE, Baker TB. 1994. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. Journal of the American Medical Association 271:1940-1947.
7. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. 1992. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addictive Behaviors 17:367-377.
8. Gilbert DG, McClernon FJ, Rabinovich NE, Plath LC, Jensen RA, Meliska CJ. 1998. Effects of smoking abstinence on mood and craving in men: influences of negative-affect-related personality traits, habitual nicotine intake, and repeated measurements. Personality and Individual Differences 25:399-423.
9. Gross J, Stitzer ML. 1989. Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology 98:334-341.
10. Henningfield JE. 1995. Nicotine medications for smoking cessation. New England Journal of Medicine 333:1196-1203.
11. Hughes JR, Gust SW, Skoog K, Keenan R, Fenwick JW. 1991. Symptoms of tobacco withdrawal: a replication and extension. Archives of General Psychiatry 48:52-59.
12. Hughes JR, Hatsukami DK. 1986. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43:289-294.
13. Hughes JR. 1992. Tobacco withdrawal in self-quitters. Journal of Counseling and Clinical Psychology 60:689-697.
14. Hurt RD, Dale LC, Fredrickson PA, Caldwell C, Lee GA, Offord KP, Lauger GG, Marusic Z, Neese LW, Lundberg TG. 1994. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. Journal of the American Medical Association 271:595-600.
15. Jorenby DE, Hatsukami DK, Smith SS, Fiore MC, Allen S, Jensen J, Baker TB. 1996. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology 128:130-138.
16. Killen JD, Fortmann SP, Kraemer HC, Varady A, Newman B. 1992. Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. Journal of Consulting and Clinical Psychology 60:797-801.
17. Piasecki TM, Fiore MC, Baker TB. 1998. Profiles in discouragement: Two studies of variability in the time course of smoking withdrawal symptoms. Journal of Abnormal Psychology 2:238-251.
18. Po ALW. 1993. Transdermal nicotine in smoking cessation: A meta-analysis. European Journal of Clinical Pharmacology 45:519-528.
19. Richmond RL, Harris K, de Almeida Neto A. 1994. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Medical Journal of Australia 161:130-135.
20. Russell MAH, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Connor P. 1993. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. British Medical Journal 306:1308-1312.
21. Shiffman S, Elash CA, Paton SM, Gwaltney CJ, Paty JA, Clark DB, Liu KS, DiMarino ME. 2000. Comparitive efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction 95:1185-1195.
22. Shiffman S, Paty JA, Rohay JM, Di Marino ME, Gitchell J. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy. Drug and Alcohol Dependence, in press.
23. Shiffman S. 1979. The tobacco withdrawal syndrome. In: Krasnegor NA, ed. Cigarette Smoking as a Dependence Process. NIDA Research Monograph 23, DHEW Publication No. (ADM) 79-800, pp. 158-184.
24. Silagy C, Mant D, Fowler G, Lancaster T. 1998. Nicotine replacement therapy for smoking cessation. Cochrane Library: 1-24.
25. Silagy C, Mant D, Fowler G, Lodge M. 1994. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343:139-142.
26. Stapleton JA, Russell MAH, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Wiseman D. 1995. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 90:31-42.
27. Stone AA, Shiffman S. 1994. Ecological momentary assessment in behavioral medicine. Annals of Behavioral Medicine 16:199-202.
28. Tang JL, Law M, Wald N. 1994. How effective is nicotine replacement therapy in helping people to stop smoking? British Medical Journal 308:324-329.
29. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saraccis R, Gulsvik A, Rijcken B, Sawe U. 1999. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. European Respiratory Journal 13:238-245.
30. Transdermal Nicotine Study Group. 1991. Transdermal nicotine for smoking cessation. Journal of the American Medical Association 266:3133-3138.
31. US Department of Health and Human Services. 1990. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. DHHS Publication No. (CDC) 90-8416. Washington, DC: US Government Printing Office.
32. US Department of Health and Human Services. 1996. Smoking Cessation: Clinical Practice Guidelines. DHHS Publication No. (AHCPR) 96-0892. Washington, DC: US Government Printing Office.
33. West R, Schneider N. 1987. Craving for cigarettes. British Journal of Addiction 82:407-415.
34. West RJ, Hajek P, Belcher M. 1989. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychological Medicine 19:981-985.
35. West RJ, Hajek P, Belcher M. 1989. Time course of cigarette withdrawal symptoms while using nicotine gum. Psychpharmacology 99:143-145.
36. Westman EC, Levin ED, Rose JE. 1993. The nicotine patch in smoking cessation: a randomized trial with telephone counseling. Archives of Internal Medicine 153:1917-1923.
37. World Health Organization. 1999. Making a Difference. World Health Report, Geneva, Switzerland.